Under the supervision of the Dean of the College of Pharmacy, Professor Dr. Sarmed H. Kathem Alkhateeb, the Scientific Affairs Unit at the University of Baghdad/College of Pharmacy held an in-person scientific seminar entitled “Evaluation of the Protective Effects of Chromium Picolinate Supplements in Doxorubicin Induced Cardiotoxicity in a Rat Model” delivered by Pharmacist Asmaa Muhammad Khalifa, the MSc student at the Pharmacology and Toxicology Department.The seminar aimed to evaluate the cardioprotective effects of chromium picolinate in doxorubicin-induced cardiotoxicity and inflammation in male rats.The seminar included several topics, including the cardiotoxic profile of doxorubicin and the therapeutic potential of chromium picolinate. Doxorubicin is a highly effective antineoplastic agent employed in the treatment of a wide range of malignancies. Despite its efficacy, its clinical use is significantly hampered by its potential to induce severe cardiotoxicity, which could be life-threatening. Inflammation and oxidative stress contribute to myocardial injury and dysfunction. Chromium picolinate, a biologically essential trace element with potent antioxidant and anti-inflammatory properties.The seminar concluded that chromium picolinate exerts a protective effect against doxorubicin-induced cardiotoxicity. Its antioxidant and anti-inflammatory capabilities make it a promising candidate as a supportive therapeutic agent during chemotherapy. These findings indicate that chromium picolinate may serve as a cytoprotective compound, potentially reducing the cardiac side effects in patients undergoing doxorubicin treatment.
